Spot Scanning Proton Beam Therapy in the Curative Treatment of Adult Patients With Sarcoma: The Paul Scherrer Institute Experience

Author(s):  
D.C. Weber ◽  
G. Goitein ◽  
H. Rutz ◽  
A. Bolsi ◽  
A. Lomax
2011 ◽  
Vol 99 ◽  
pp. S370
Author(s):  
D.C. Weber ◽  
R. Schneider ◽  
T. Koch ◽  
C. Ares ◽  
G. Goitein ◽  
...  

2006 ◽  
Vol 21 (1) ◽  
pp. 58-60
Author(s):  
Dragan Toprek

The results of beam profile measurements of the proton beam of the ACCEL K250 superconducting cyclotron at the Paul Scherrer Institute are presented in this paper. Beam emittances in both horizontal and vertical planes are estimated by the varying quadrupole method.


PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e94971 ◽  
Author(s):  
Shinichi Shimizu ◽  
Naoki Miyamoto ◽  
Taeko Matsuura ◽  
Yusuke Fujii ◽  
Masumi Umezawa ◽  
...  

Rare Tumors ◽  
2019 ◽  
Vol 11 ◽  
pp. 203636131987851 ◽  
Author(s):  
Nathan Y Yu ◽  
Sujay A Vora

Retroperitoneal chordomas are exceedingly rare and account for less than 5% of all primary bone malignancies. Their etiology remains unknown. We report a rare case of an extravertebral chordoma of the retroperitoneum in a 71-year-old man treated with surgical resection and post-operative spot-scanning proton beam therapy. We describe how to safely treat a retroperitoneal target to a prescription dose over 70 Gy (relative biological effectiveness) with spot-scanning proton beam therapy and also report a dosimetric comparison of spot-scanning proton beam therapy versus intensity-modulated radiation therapy. This case not only highlights a rare diagnosis of an extravertebral retroperitoneal chordoma but it also draws attention to the dosimetric advantages of proton beam therapy and illustrates a promising radiotherapeutic option for retroperitoneal targets.


Sign in / Sign up

Export Citation Format

Share Document